相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals
Francesco Asnicar et al.
NATURE MEDICINE (2021)
Cardiovascular disease in diabetes, beyond glucose
Robert H. Eckel et al.
CELL METABOLISM (2021)
Atorvastatin Targets the Islet Mevalonate Pathway to Dysregulate mTOR Signaling and Reduce β-Cell Functional Mass
Linyan Shen et al.
DIABETES (2020)
Fermentation Products of Commensal Bacteria Alter Enterocyte Lipid Metabolism
Joao R. Araujo et al.
CELL HOST & MICROBE (2020)
A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors
Ina Nemet et al.
CELL (2020)
Gut Microbiota and Cardiovascular Disease
Marco Witkowski et al.
CIRCULATION RESEARCH (2020)
Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level
Douglas J. Kenny et al.
CELL HOST & MICROBE (2020)
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE ALGORITHM-2020 EXECUTIVE SUMMARY
Yehuda Handelsman et al.
ENDOCRINE PRACTICE (2020)
Berberine attenuates the abnormal ectopic lipid deposition in skeletal muscle
Shuangshuang Yao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
1,520 reference genomes from cultivated human gut bacteria enable functional microbiome analyses
Yuanqiang Zou et al.
NATURE BIOTECHNOLOGY (2019)
Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study
Massimiliano Ruscica et al.
NUTRITION JOURNAL (2019)
Urinary bisphenol A concentration and glucose homeostasis in non-diabetic adults: a repeated-measures, longitudinal study
Bin Wang et al.
DIABETOLOGIA (2019)
Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease Data From UK Biobank
Claire Welsh et al.
CIRCULATION (2019)
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives
Natalia Vallianou et al.
CURRENT OBESITY REPORTS (2019)
The intestinal microbiota programs diurnal rhythms in host metabolism through histone deacetylase 3
Zheng Kuang et al.
SCIENCE (2019)
Bach2 deficiency leads autoreactive B cells to produce IgG autoantibodies and induce lupus through a T cell-dependent extrafollicular pathway
Eunkyeong Jang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Nonfasting versus fasting lipid profile for cardiovascular risk prediction
Anne Langsted et al.
PATHOLOGY (2019)
Comprehensive Strategy to Construct In-House Database for Accurate and Batch Identification of Small Molecular Metabolites
Xinjie Zhao et al.
ANALYTICAL CHEMISTRY (2018)
Small Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary Lipids
Kristina Martinez-Guryn et al.
CELL HOST & MICROBE (2018)
A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma
Ping Luo et al.
HEPATOLOGY (2018)
Role of Bile Acids in Metabolic Control
Antonio Molinaro et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
Ion-Pair Selection Method for Pseudotargeted Metabolomics Based on SWATH MS Acquisition and Its Application in Differential Metabolite Discovery of Type 2 Diabetes
Lichao Wang et al.
ANALYTICAL CHEMISTRY (2018)
Nonfasting Triglycerides, Low-Density Lipoprotein Cholesterol, and Heart Failure Risk Two Cohort Studies of 113 554 Individuals
Anette Varbo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice
Francine Z. Marques et al.
CIRCULATION (2017)
Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention
Ruixin Liu et al.
NATURE MEDICINE (2017)
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Arrigo F. G. Cicero et al.
NUTRITION REVIEWS (2017)
Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment
Yanyun Gu et al.
NATURE COMMUNICATIONS (2017)
Exogenous fatty acid metabolism in bacteria
Jiangwei Yao et al.
BIOCHIMIE (2017)
A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence
Vivencio Barrios et al.
ATHEROSCLEROSIS SUPPLEMENTS (2017)
Clinical Update: Cardiovascular Disease in Diabetes Mellitus Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations
Cecilia C. Low Wang et al.
CIRCULATION (2016)
Gut microbiome and lipid metabolism: from associations to mechanisms
Zheng Wang et al.
CURRENT OPINION IN LIPIDOLOGY (2016)
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2016)
Lipid-modifying effects of nutraceuticals: An evidence-based approach
Amirhossein Sahebkar et al.
NUTRITION (2016)
Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies
Angela Pirillo et al.
ATHEROSCLEROSIS (2015)
Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
Fredrik Backhed et al.
CELL HOST & MICROBE (2015)
Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III) Reply
Bethany Doran et al.
CIRCULATION (2015)
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association
Larry M. Baddour et al.
CIRCULATION (2015)
The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids
Jingyuan Fu et al.
CIRCULATION RESEARCH (2015)
The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial
K. L. Ivey et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2015)
A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion
Ryan E. Temel et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests
Yuying Deng et al.
JOURNAL OF DIABETES (2015)
Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and Hyde scenario
Sy-Bing Choi et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2015)
Development of Urinary Pseudotargeted LC-MS-Based Metabolomics Method and Its Application in Hepatocellular Carcinoma Biomarker Discovery
Yaping Shao et al.
JOURNAL OF PROTEOME RESEARCH (2015)
New and emerging regulators of intestinal lipoprotein secretion
Changting Xiao et al.
ATHEROSCLEROSIS (2014)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
David C. Goff et al.
CIRCULATION (2014)
Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality Insight From the National Health and Nutrition Examination Survey III (NHANES-III)
Bethany Doran et al.
CIRCULATION (2014)
LDL Cholesterol as a Predictor of Mortality, and Beyond To Fast or Not to Fast, That Is the Question?
Robert H. Eckel
CIRCULATION (2014)
Bifidobacteria supplementation: Effects on plasma lipid profiles in dyslipidemic children
Ornella Guardamagna et al.
NUTRITION (2014)
Berberine activates thermogenesis in white and brown adipose tissue
Zhiguo Zhang et al.
NATURE COMMUNICATIONS (2014)
Clinical Considerations and Mechanistic Determinants of Postprandial Lipemia in Older Adults
Christos S. Katsanos
ADVANCES IN NUTRITION (2014)
Cholesterol-lowering probiotics: in vitro selection and in vivo testing of bifidobacteria
Alessandra Bordoni et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2013)
Transintestinal Cholesterol Excretion Is an Active Metabolic Process Modulated by PCSK9 and Statin Involving ABCB1
Cedric Le May et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
Richard Haynes et al.
EUROPEAN HEART JOURNAL (2013)
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
W. H. Wilson Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats
Xu Zhang et al.
PLOS ONE (2012)
Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes
Lutgarda Bozzetto et al.
ATHEROSCLEROSIS (2011)
Extensive Intestinal First-Pass Elimination and Predominant Hepatic Distribution of Berberine Explain Its Low Plasma Levels in Rats
Yi-Tong Liu et al.
DRUG METABOLISM AND DISPOSITION (2010)
The gut microbiota modulates host energy and lipid metabolism in mice
Vidya R. Velagapudi et al.
JOURNAL OF LIPID RESEARCH (2010)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
Multivariate paired data analysis: multilevel PLSDA versus OPLSDA
Johan A. Westerhuis et al.
METABOLOMICS (2010)
Intestinal lipoprotein overproduction in insulin-resistant states
Khosrow Adeli et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine
Yifei Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Borge G. Nordestgaard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in china
J He et al.
CIRCULATION (2004)
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
WJ Kong et al.
NATURE MEDICINE (2004)
Bacterial long chain fatty acid transport: Gateway to a fatty acid-responsive signaling system
CC DiRusso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Transmembrane movement of exogenous long-chain fatty acids: Proteins, enzymes, and vectorial esterification
PN Black et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2003)
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
SM Grundy et al.
CIRCULATION (2002)
Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance -: Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction
M Haidari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Functional role of fatty acyl-coenzyme A synthetase in the transmembrane movement and activation of exogenous long-chain fatty acids -: Amino acid residues within the ATP/AMP signature motif of Escherichia coli FadD are required for enzyme activity and fatty acid transport
JD Weimar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
